Paramita Therapeutics, Inc
Paramita Therapeutics, Inc. is an early-stage biotech startup based in San Diego, CA, founded in 2018 by Drs. Sang Van and Jack Bui. Specializing in the development of targeted immunotherapies, Paramita utilizes their proprietary water-soluble multivalent conjugation platform technologies to combat cancer and infectious diseases, such as COVID-19.
Despite facing setbacks due to the pandemic, Paramita secured pre-seed funding in 2018 and received a Phase 1 small business innovation research (SBIR) award from the National Science Foundation (NSF) in 2021. With a focus on developing dual-function therapeutic and vaccine products, Paramita aims to complete preclinical and toxicology studies for advanced prostate and ovarian cancer.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.